Items where authors include "Gouin, F."

Article

Panez-Toro, I., Heymann, D. orcid.org/0000-0001-7777-0669, Gouin, F. et al. (3 more authors) (2023) Roles of inflammatory cell infiltrate in periprosthetic osteolysis. Frontiers in Immunology, 14. 1310262. ISSN 1664-3224

Chalopin, A., Tellez-Gabriel, M., Brown, H.K. et al. (4 more authors) (2018) Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy. Journal of Bone Oncology, 12. pp. 83-90. ISSN 2212-1374

Brown, H.K., Schiavone, K., Gouin, F. et al. (2 more authors) (2018) Biology of bone sarcomas and new therapeutic developments. Calcified Tissue International, 102 (2). pp. 174-195. ISSN 0171-967X

Crenn, V., Biteau, K., Amiaud, J. et al. (8 more authors) (2017) Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy : retrospective analysis and preclinical modeling. American Journal of Cancer Research, 7 (11). pp. 2333-2349.

Aubin, G.G., Baud'huin, M., Lavigne, J.P. et al. (7 more authors) (2017) Interaction of Cutibacterium (formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development. Scientific Reports, 7. 42918. ISSN 2045-2322

Brulefert, K., Córdova, L.A., Brulin, B. et al. (7 more authors) (2016) Pro-osteoclastic In Vitro Effect of Polyethylene-like Nanoparticles: Involvement in the Pathogenesis of Implant Aseptic Loosening. Journal of Biomedical Research Part A, 104 (11). pp. 2649-2657. ISSN 1549-3296

Dumars, C., Nguyen, J.M., Gaultier, A. et al. (5 more authors) (2016) Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Oncotarget, 7. pp. 78343-78354. ISSN 0032-0889

Cordova, L.A., Trichet, V., Escriou, V. et al. (10 more authors) (2015) Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model. Acta Biomaterialia, 13. pp. 150-158. ISSN 1742-7061

Cordova, L.A., Stresing, V., Gobin, B. et al. (6 more authors) (2014) Orthopaedic implant failure: aseptic implant loosening--the contribution and future challenges of mouse models in translational research. Clinical Science, 127 (5). pp. 277-293. ISSN 0143-5221

Odri, G., Kim, P-P., Lamoureux, F. et al. (6 more authors) (2014) Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration. BMC Cancer, 14. 169. ISSN 1471-2407

Monderer, D., Luseau, A., Bellec, A. et al. (14 more authors) (2013) New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. Laboratory Investigation, 93 (10). pp. 1100-1114. ISSN 0023-6837

Georges, S., Chesneau, J., Hervouet, S. et al. (7 more authors) (2013) A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis. European Journal of Cancer, 49 (9). pp. 2253-2263. ISSN 0959-8049

Miot-Noirault, E., David, E., Vidal, A. et al. (8 more authors) (2013) Tc-99m-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model. EJNMMI Research, 3. 40. ISSN 2191-219X

Peyrode, C., Weber, V., David, E. et al. (10 more authors) (2012) Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies. Investigational New Drugs, 30 (4). pp. 1782-1790. ISSN 0167-6997

Battaglia, S., Dumoucel, S., Chesneau, J. et al. (6 more authors) (2011) Impact of Oncopediatric Dosing Regimen of Zoledronic Acid on Bone Growth: Preclinical Studies and Case Report of an Osteosarcoma Pediatric Patient. Journal of Bone and Mineral Research, 26 (10). pp. 2439-2451. ISSN 0884-0431

David, E., Guihard, P., Brounais, B. et al. (10 more authors) (2011) Direct anti-cancer effect of oncostatin M on chondrosarcoma. International Journal of Cancer, 128 (8). pp. 1822-1835. ISSN 0020-7136

David, E., Blanchard, F., Heymann, M.F. et al. (4 more authors) (2011) The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. Sarcoma, 2011. 932451. ISSN 1357-714X

Peyrode, C., Gouin, F., Vidal, A. et al. (8 more authors) (2011) A“Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model. Sarcoma, 2011. 691608. ISSN 1357-714X

Odri, G.A., Dumoucel, S., Picarda, G. et al. (10 more authors) (2010) Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients. Cancer Research, 70 (19). pp. 7610-7619. ISSN 0008-5472

Perrot, P., Rousseau, J., Bouffaut, A-L. et al. (8 more authors) (2010) Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence. PLOS ONE, 5 (6). e10999. ISSN 1932-6203

Baud'Huin, M., Renault, R., Charrier, C. et al. (6 more authors) (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. Journal of Pathology, 221 (1). pp. 77-86. ISSN 0022-3417

Moriceau, G., Ory, B., Gobin, B. et al. (5 more authors) (2010) Therapeutic Approach of Primary Bone Tumours by Bisphosphonates. Current Pharmaceutical Design, 16 (27). pp. 2981-2987. ISSN 1381-6128

Lamoureux, F., Ory, B., Battaglia, S. et al. (6 more authors) (2008) Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid. International Journal of Cancer, 122 (4). pp. 751-760. ISSN 0020-7136

Lamoureux, F., Richard, P., Wittrant, Y. et al. (8 more authors) (2007) Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: Blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Research, 67 (15). pp. 7308-7318. ISSN 0008-5472

Mori, K., Le Goff, B., Berreur, M. et al. (11 more authors) (2007) Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. The Journal of Pathology, 211 (5). pp. 555-562. ISSN 0022-3417

Ory, B., Blanchard, F., Battaglia, S. et al. (3 more authors) (2007) Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status. Molecular Pharmacology, 71 (1). pp. 333-343. ISSN 0026-895X

Gouin, F., Ory, B., Redini, F. et al. (1 more author) (2006) Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival. International Journal of Cancer, 119 (5). pp. 980-984. ISSN 0020-7136

Mori, K., Redini, F., Gouin, F. et al. (2 more authors) (2006) Osteosarcoma: Current status of immunotherapy and future trends (Review). Oncology Reports, 15 (3). pp. 693-700. ISSN 1021-335X

Ory, B., Heymann, M.F., Kamijo, A. et al. (3 more authors) (2005) Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice. Cancer, 104 (11). pp. 2522-2529. ISSN 0008-543X

Theoleyre, S., Mori, K., Cherrier, B. et al. (4 more authors) (2005) Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma. BMC Cancer, 5. 123. ISSN 1471-2407

Heymann, D. orcid.org/0000-0001-7777-0669, Ory, B., Blanchard, F. et al. (7 more authors) (2005) Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. Bone , 37 (1). pp. 74-86. ISSN 8756-3282

Cherrier, B., Gouin, F., Heymann, M.F. et al. (4 more authors) (2005) A new experimental rat model of osteosarcoma established by intrafemoral tumor cell inoculation, useful for biology and therapy investigations. Tumor Biology, 26 (3). pp. 121-130. ISSN 1010-4283

Heymann, D. orcid.org/0000-0001-7777-0669, Ory, B., Gouin, F. et al. (2 more authors) (2004) Bisphosphonates: new therapeutic agents for the treatment of bone tumors. Trends in Molecular Medicine, 10 (7). pp. 337-343. ISSN 1471-4914

Grimaud, E., Soubigou, L., Couillaud, S. et al. (6 more authors) (2003) Receptor activator of nuclear factor kappa B ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. The American Journal of Pathology, 163 (5). pp. 2021-2031. ISSN 0002-9440

Grimaud, E., Damiens, C., Rousselle, A.V. et al. (3 more authors) (2002) Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma. Histology and Histopathology, 17 (4). pp. 1103-1111. ISSN 0213-3911